Gradient of electro-convulsive therapy's antidepressant effects along the longitudinal hippocampal axis.
Journal
Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664
Informations de publication
Date de publication:
29 03 2021
29 03 2021
Historique:
received:
18
07
2020
accepted:
02
03
2021
revised:
12
02
2021
entrez:
30
3
2021
pubmed:
31
3
2021
medline:
29
6
2021
Statut:
epublish
Résumé
Despite decades of successful treatment of therapy-resistant depression and major scientific advances in the field, our knowledge about electro-convulsive therapy's (ECT) mechanisms of action is still scarce. Building on strong empirical evidence for ECT-induced hippocampus anatomy changes, we sought to test the hypothesis that ECT has a differential impact along the hippocampus longitudinal axis. We acquired behavioural and brain anatomy magnetic resonance imaging (MRI) data in patients with depressive episode undergoing ECT (n = 9) or pharmacotherapy (n = 24) and healthy controls (n = 30) at two time points 3 months apart. Using whole-brain voxel-based statistical parametric mapping and topographic analysis focused on the hippocampus, we observed ECT-induced gradient of grey matter volume increase along the hippocampal longitudinal axis with predominant impact on its anterior portion. Clinical outcome measures showed strong correlations with both baseline volume and rate of ECT-induced change exclusively for the anterior, but not posterior hippocampus. We interpret our findings confined to the anterior hippocampus and amygdala as additional evidence of the regional specific impact of ECT that unfolds its beneficial effect on depression via the "limbic" system. Main limitations of the study are patients' polypharmacy, heterogeneity of psychiatric diagnosis, and long-time interval between scans.
Identifiants
pubmed: 33782387
doi: 10.1038/s41398-021-01310-0
pii: 10.1038/s41398-021-01310-0
pmc: PMC8007583
doi:
Substances chimiques
Antidepressive Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
191Subventions
Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation)
ID : 32003B_159780
Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation)
ID : 324730_192755
Références
Proc Natl Acad Sci U S A. 2019 Oct 8;116(41):20750-20759
pubmed: 31548375
Biol Psychiatry. 2016 Feb 15;79(4):282-92
pubmed: 25842202
Acta Psychiatr Scand. 2005 Oct;112(4):257-65
pubmed: 16156832
Neuroimage. 2017 Feb 15;147:746-762
pubmed: 27979788
Transl Psychiatry. 2014 Nov 18;4:e483
pubmed: 25405780
Neuroscience. 1998 Sep;86(2):449-59
pubmed: 9881860
Biol Psychiatry. 2000 Jun 15;47(12):1043-9
pubmed: 10862803
Brain Struct Funct. 2016 Jul;221(6):2999-3012
pubmed: 26206251
Proc Natl Acad Sci U S A. 2014 Jan 21;111(3):1156-61
pubmed: 24379394
Nat Commun. 2020 Feb 19;11(1):960
pubmed: 32075960
Ecol Lett. 2010 Feb;13(2):246-64
pubmed: 20102373
Hippocampus. 2017 Jan;27(1):52-60
pubmed: 27756104
Brain Stimul. 2019 Mar - Apr;12(2):335-343
pubmed: 30554869
Emotion. 2012 Feb;12(1):58-68
pubmed: 22309734
Hum Brain Mapp. 2016 Feb;37(2):462-76
pubmed: 26538342
Biol Psychiatry. 2007 Sep 1;62(5):505-12
pubmed: 17336937
J Neuroendocrinol. 1995 Jun;7(6):475-82
pubmed: 7550295
Neuroimage Clin. 2017 Feb 14;14:422-432
pubmed: 28275543
J ECT. 2014 Jun;30(2):143-51
pubmed: 24810772
Neuroimage. 2019 May 15;192:38-51
pubmed: 30840906
Brain Res. 2013 Jan 23;1491:88-97
pubmed: 23123207
Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):15238-43
pubmed: 25246561
Hum Brain Mapp. 2016 May;37(5):1801-15
pubmed: 26876452
Neuropsychopharmacology. 2015 Jan;40(1):113-28
pubmed: 25178407
Nat Neurosci. 2011 Sep 25;14(11):1413-5
pubmed: 21946328
Neuron. 2010 Jan 14;65(1):7-19
pubmed: 20152109
Front Neurosci. 2013 Feb 05;6:197
pubmed: 23386806
Neuron. 2015 Sep 2;87(5):1093-105
pubmed: 26298276
Exp Neurol. 2000 Oct;165(2):231-6
pubmed: 10993683
JAMA Psychiatry. 2016 Jun 1;73(6):557-64
pubmed: 27145449
Neuroimage. 2016 Apr 15;130:157-166
pubmed: 26854557
Br J Psychiatry. 2018 Jan;212(1):19-26
pubmed: 29433612
Mol Psychiatry. 2020 Jul;25(7):1559-1568
pubmed: 30867562
Eur Neuropsychopharmacol. 2009 May;19(5):329-38
pubmed: 19176277
Cortex. 2016 Aug;81:104-17
pubmed: 27182810
Science. 2005 Jun 17;308(5729):1792-4
pubmed: 15961670
Biol Psychiatry. 2005 Dec 1;58(11):871-8
pubmed: 16043138
Nat Rev Neurosci. 2017 Jun;18(6):335-346
pubmed: 28469276
Lancet. 2003 Mar 8;361(9360):799-808
pubmed: 12642045
Biol Psychiatry. 2016 Feb 15;79(4):264-5
pubmed: 26796876
Neuropsychopharmacology. 2018 Apr;43(5):1078-1087
pubmed: 28758644
Biol Psychiatry. 2018 Oct 15;84(8):574-581
pubmed: 30006199
Neuropsychopharmacology. 2006 Jan;31(1):212-20
pubmed: 16123748
Neuroimage. 2015 Jun;113:44-60
pubmed: 25776219
Trends Psychiatry Psychother. 2015 Jan-Mar;37(1):27-36
pubmed: 25860564
Neuropsychopharmacology. 2019 Sep;44(10):1805-1811
pubmed: 30622299
Nat Rev Neurosci. 2014 Oct;15(10):655-69
pubmed: 25234264
Neuropsychopharmacology. 2013 Sep;38(10):1889-98
pubmed: 23673864
Can J Neurol Sci. 1977 Nov;4(4):273-8
pubmed: 597802
Neuroimage. 2012 Mar;60(1):83-94
pubmed: 22173294
Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 May;2(4):327-335
pubmed: 28989984
Acta Psychiatr Scand. 2018 Sep;138(3):180-195
pubmed: 29707778